中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 9
Sep.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(9): 2167-2170

Practice and thinking on constructing a scientific research system for regional liver pathology center under the concept of collaborative innovation

DOI: 10.3969/j.issn.1001-5256.2021.09.031
  • 1a.

    Department of Pathology, Wuxi Second People's Hospital, Wuxi, Jiangsu 214002, China

  • 1b.

    Department of Gastroenterology, Wuxi Second People's Hospital, Wuxi, Jiangsu 214002, China

  • 2.

    Department of Infectious Diseases, Wuxi Fifth People's Hospital, Wuxi, Jiangsu 214011, China

Research funding:

Key Soft Project of Wuxi Science and Technology Association (KX-20-B64)

  • Received Date: 2021-01-10
  • Accepted Date: 2021-04-12
  • Published Date: 2021-09-20
    Abstract
  •   Objective  To investigate the influence of the concept of collaborative innovation on the construction of a scientific research system for regional liver pathology center from multiple perspectives, and to explore its application significance.  Methods  A total of 1246 liver biopsy specimens which were examined in Department of Pathology in Wuxi Second People's Hospital and Wuxi Fifth People's Hospital from January 2014 to September 2020 were collected, among which the specimens examined before the founding of the regional liver pathology center were collected as nI group, and those examined after the founding of the center were collected as nII group. According to the examination time of the first, second, or third year after founding, the nII group was further divided into nIIa group, nIIb group, and nIIc group. A multi-perspective analysis was performed based on five indices, i.e., number of liver biopsy specimens, growth rate of liver biopsy specimens, growth rate of internal collaborative departments, growth rate of external collaborative units, and evaluation of the collaborative and innovative scientific research system.  Results  The growth rate of liver biopsy specimens in the nI group was 15.51%; after the founding of the regional liver pathology center, the highest growth rate of 187.76% was observed in the nIIa group, and a relatively stable growth rate of 76.35% was observed in the nIIb group. There was a gradual increase in the number of specimens in internal collaborative departments, with a growth rate of 50% in the nIIa group and 83.33% in the nIIb group, while the number of external collaborative units increased steadily, with a growth rate of 100% in the nIIa group and 50% in the nIIb group. The nII group showed a diversified increasing trend in the evaluation indices of the scientific research system.  Conclusion  It is a new perspective for the construction of regional disciplinary scientific research system to grasp the opportunity of policy-supported development and innovate the effective cooperation mode between internal departments and external units under the concept of collaborative innovation.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    GAO HJ. Practice and thinking on the construction of new clinical medicine discipline of "patient-centered"[J]. Natl Med J China, 2020, 11(40): 3126-3129. DOI: 10.3760/cma.j.cn112137-20200324-00911.

    郜恒骏. "以患者为中心"新型临床医学学科建设的实践与思考[J]. 中华医学杂志, 2020, 11(40): 3126-3129. DOI: 10.3760/cma.j.cn112137-20200324-00911.
    [2]
    VERONICA S, THOMAS F. Collaborative innovation in ubiquitous systems[J]. J Intell Manuf, 2007, 18(5): 599-615. DOI: 10.1007/s10845-007-0064-2.
    [3]
    HINRICHS MM, SEAGER TP, TRACY SJ, et al. Innovation in the knowledge age: Implications for collaborative science[J]. Environ Syst Decis, 2017, 37(2): 144-155. DOI: 10.1007/s10669-016-9610-9.
    [4]
    van WEEL C, TURNBULL D, WHITEHEAD E, et al. International collaboration in innovating health systems[J]. Ann Fam Med, 2015, 13(1): 86-87. DOI: 10.1370/afm.1751.
    [5]
    GOUGET B, TOUIMI B, JELLOUN M. The fifbcml: A mediterranean-leading platform for collaboration and innovation in lab medical[J]. Clin Chem Lab Med, 2017, 55: s131. DOI: 10.1515/cclm-2017-5001.
    [6]
    RUAN B, YU Z, YANG S, et al. Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China[J]. BMC Infect Dis, 2019, 19(1): 617. DOI: 10.1186/s12879-019-4150-9.
    [7]
    POYAN MEHR A, SADEGHI-NAJAFABADI M, CHAU K, et al. The glomerular disease study and trial consortium: A grassroots initiative to foster collaboration and innovation[J]. Kidney Int Rep, 2019, 4(1): 20-29. DOI: 10.1016/j.ekir.2018.09.012.
    [8]
    BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
    [9]
    XIAO J, WANG F, WONG NK, et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective[J]. J Hepatol, 2019, 71(1): 212-221. DOI: 10.1016/j.jhep.2019.03.004.
    [10]
    TAPPER EB, LOK AS. Use of liver imaging and biopsy in clinical practice[J]. N Eng J Med, 2017, 377(8): 756-768. DOI: 10.1056/NEJMra1610570.
    [11]
    TORBENSON M, WASHINGTON K. Pathology of liver disease: Advances in the last 50 years[J]. Hum Pathol, 2020, 95: 78-98. DOI: 10.1016/j.humpath.2019.08.023.
    [12]
    TANG H, XU RR, JIANG LL, et al. A study of construction strategy for regional clinical pathology center of liver disease based on SWOT analysis[J]. J Clin Hepatol, 2019, 35(7): 1582-1584. DOI: 10.3969/j.issn.1001-5256.2019.07.031.

    汤鸿, 徐蓉蓉, 蒋丽琳, 等. 基于SWOT分析法的区域性肝病临床病理研究中心建设策略[J]. 临床肝胆病杂志, 2019, 35(7): 1582-1584. DOI: 10.3969/j.issn.1001-5256.2019.07.031.
    [13]
    FU L, YIN L, ZHU ML, et al. Innovation system construction for China's basic and clinical medcine[J]. Eng Sci, 2017, 19(2): 72-78. DOI: 10.15302/J-SSCAE-2017.02.012.

    付磊, 尹岭, 朱曼璐, 等. 我国基础与临床医学创新体系建设研究[J]. 中国工程科学, 2017, 19(2): 72-78. DOI: 10.15302/J-SSCAE-2017.02.012.
    [14]
    ESLAM M, SANYAL AJ, GEORGE J, et al. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease[J]. Gastroenterology, 2020, 158(7): 1999-2014. DOI: 10.1053/j.gastro.2019.11.312.
    [15]
    TANAKA N, KIMURA T, FUJIMORI N, et al. Current status, problems, and perspectives of non-alcoholic fatty liver disease research[J]. World J Gastroenterol, 2019, 25(2): 163-177. DOI: 10.3748/wjg.v25.i2.163.
    [16]
    LI LJ, ZHENG SS, CHEN Z, et al. Theoretical innovation and technical breakthrough in the diagnosis and treatment of severe liver disease[J]. China Sci Technol Achievements, 2014, 15(1): 64-66. DOI: 10.3772/j.issn.1009-5659.2014.01.025.

    李兰娟, 郑树森, 陈智, 等. 重症肝病诊治的理论创新与技术突破[J]. 中国科技成果, 2014, 15(1): 64-66. DOI: 10.3772/j.issn.1009-5659.2014.01.025.
    [17]
    CHESBROUGH H. Open innovation: Where we've been and where we're going: The father of open innovation offers his assessment of the history and future of the model[J]. Res Technol Manage, 2012, 55(4): 20-27. DOI: 10.5437/08956308X5504085.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (312) PDF downloads(21) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return